Patent · US Active

GPR120 receptor agonists and uses thereof

US8309600B2 · kind B2 · utility

0Cited by
8References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2009
Grant dateNov 13, 2012
Priority date—
Expiry dateNov 21, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D407/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.